Aim and editorial policy
Revista Brasileira de Psiquiatria is a quarterly publication that aims to publish original manuscripts in all areas of psychiatry, including public health, clinical epidemiology, basic science, and mental health problems. Articles should be written in English.
These instructions were written based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications, edited by the International Committee of Medical Journal Editors (ICMJE). The original document is available at http://www.icmje.org/.
Revista Brasileira de Psiquiatria supports the clinical trial registration policies of the World Health Organization (WHO) and the ICMJE, recognizing the importance of such initiatives for the registration and disclosure of trial results to the international community through open access. According to this recommendation and to the BIREME/OPAS/OMS guidelines for journals indexed in the LILACS and SciELO databases, Revista Brasileira de Psiquiatria will only accept for publication clinical trials that have been registered in Clinical Trials Registries that meet the WHO and ICMJE requirements (URLs available at http://www.icmje.org/faq_clinical.html; a Brazilian registry is also available at http://www.ensaiosclinicos.gov.br/). The clinical trial registration number should be informed at the end of the abstract.
Peer review processThe selection of manuscripts for publication is based on their originality, relevance of the topic, methodological quality, and compliance with these instructions. All manuscripts considered for publication are peer-reviewed by anonymous external referees. Whenever possible, an editorial decision (acceptance, revisions required, or rejection) will be made within one month after submission.
Revista Brasileira de Psiquiatria publishes original articles, brief communications, review articles, update articles, editorials, and letters to the Editor. Consult a current issue of the Journal for style and format. The text should be double-spaced with broad margins.
Original articles, review articles, update articles, and brief communications all follow the format described below.
Title page: Full title, authors' names, their departments and institutions, including the city and country of origin. Please also include a running title with a maximum of 50 characters (letters and spaces). The full name, telephone number, fax number, e-mail address and full postal address of the corresponding author should be stated.
Page 2: A structured abstract not exceeding 200 words with the following sections: Objective, Methods, Results, and Conclusion. Please indicate three to five keywords in strict accordance with Medical Subject Headings.Main text: The Introduction should be one to three pages long (do not extensively review the literature), concluded by a clear statement of the aims of the study. A thorough Methods section should include study design, setting, participants, main outcome measures, statistical analyses, trial registration, ethics committee approval, and informed consent procedures (avoid referring to design, method and material described in previously published articles). Results should be clear; repetition of data in the text and in tables/figures is not allowed. Discussion: Do not include a conclusion section; concluding remarks should be presented in the final paragraph of the text.
Acknowledgements: Should include grants, sponsorships and other types of support provided to the study. Some authors may wish to thank collaborators who contributed significantly to the manuscript but do not fulfill authorship criteria. It is the responsibility of the author to obtain permission from the persons mentioned.
Disclosure: Each author should disclose potential conflicts of interest in general, not only related to the present study. Examples include but are not limited to previous or current jobs/positions, research grants, speaker’s honoraria, ownership interest, and work as a consultant or advisory board for organizations. Studies that in any way involve pharmaceutical companies or other private or public enterprises should clearly disclose the role of these organizations in the study. Moreover, if the study in any way investigates pharmaceutical compounds, the Disclosure should contain information about by whom and which institutions the statistical analyses were performed and an e-mail address where to obtain the protocol.
Reference list: References should be kept to the pertinent minimum and should be numbered consecutively in the order in which they appear in the text, in accordance with the Vancouver system. We recommend the use of a tool such as Reference Manager or Endnote for reference management and formatting. Identify references in text, tables, and legends using superscript Arabic numerals. References cited only in tables or figure legends should be numbered in accordance with their first citation in the text.
Please observe the style of the examples below. To include manuscripts accepted, but not published, inform the abbreviated title of the journal followed by (in press). Papers published electronically, but not yet in print, should be identified by their DOI number. Information from manuscripts not yet accepted should be cited only in the text as personal communication. Reference accuracy is the responsibility of the authors. Journal titles should be abbreviated in accordance with Index Medicus.
Standard journal article: List all authors when six or fewer. When there are seven or more, list only the first six authors and add "et al.". Coelho FM, Pinheiro RT, Silva RA, Quevedo LA, Souza LD, Castelli RD, et al. Major depressive disorder during teenage pregnancy: socio-demographic, obstetric and psychosocial correlates. Rev Bras Psiquiatr. 2013;35:51-6.Book: Gabbard GO. Gabbard’s treatment of psychiatric disorders. 4th ed. Arlington: American Psychiatric Publishing; 2007.
Book chapter: Kennedy SH, Rizvi SJ, Giacobbe P. The nature and treatment of therapy-resistant depression. In: Cryan JF, Leonard BE, editors. Depression: from psychopathology to pharmacotherapy. Basel: Karger; 2010. p. 243-53.
Theses and dissertations: Trigeiro A. Central nervous system corticotropin releasing factor (CRF) systems contribute to increased anxiety-like behavior during opioid withdrawal: an analysis of neuroanatomical substrates [dissertation]. San Diego: University of California; 2011.
Tables and figures: All figures/tables should clarify/complement rather than repeat the text; their number should be kept to a minimum. All illustrations should be submitted on separate pages, following the order in which they appear in the text and numbered consecutively using Arabic numerals. All tables and figures should include descriptive legends, and abbreviations should be defined. Any tables or figures extracted from previously published works should be accompanied by written permission for reproduction from the current copyright holder at the time of submission.
Abbreviations and symbols: All terms or abbreviations should be spelled out at first mention and also in table/figure legends. All units should be metric. Avoid Roman numerals.
Supplementary material online
Revista Brasileira de Psiquiatria does not publish supplementary or supporting material online.
Original articles: These should describe fully, but as concisely as possible, the results of original research, containing all the relevant information for those who wish to reproduce the research or assess the results and conclusions. Original manuscripts should not exceed 5,000 words, excluding tables, figures, and references. No more than six tables or figures, and a maximum of 40 references, will be accepted. The text should be organized in the following sections: Introduction, Methods, Results, and Discussion. Clinical implications and limitations of the study should be stated. Randomized clinical trials should be registered in online clinical databases (the clinical trial registration number should be informed at the end of the abstract).
Brief communications: Original but shorter manuscripts addressing topics of interest in the field of psychiatry, with preliminary results or results of immediate relevance. These papers should be limited to 1,500 words, one table or figure, and 15 references.Review articles: These articles are preferably solicited (by the Editors) from experts in the field. They are systematic, critical assessments of
literature and data sources, aimed at critically reviewing and evaluating existing knowledge on a designated topic, in addition to commenting on studies by other authors. The search strategy and selection process (including inclusion/exclusion criteria) should be described in detail. Review articles are limited to 6,000 words, excluding tables, figures and references. The total number of tables and figures may not exceed six.
Update articles: Update articles address current information relevant to clinical practice and are less comprehensive than review articles. Update articles should be no longer than 2,000 words and 30 references.
Editorials: Critical and in-depth commentary invited by the Editors or written by a person with known expertise in the topic. Editorials should not exceed 900 words and five references. A title page should be included as described above.
Letters to the Editor: Letters can contain reports of unusual cases, comments on relevant scientific topics, critiques of editorial policy, or opinions on the contents of the journal. Letters should include a maximum of 500 words, one table, one figure, and five references.
Authors of accepted manuscripts should complete the Author Statement below and send it to firstname.lastname@example.org. To avoid any delays in publication, a signed form should be sent to the production office as soon as the manuscript is accepted for publication (not required upon submission). Production will not commence until the signed form is received.
I, the undersigned author, certify that I and all other co-authors of the manuscript no. _________________, entitled ________________________________________________________, submitted for publication in Revista Brasileira de Psiquiatria, have participated sufficiently in the intellectual content, data analysis, and writing of the manuscript, and take public responsibility for it. Also, I and each of the co-authors have reviewed the final version of the manuscript, believe it represents valid work, and approve it for publication. On behalf of all coauthors, I certify that the manuscript has not been previously published or accepted for publication, nor is it currently under consideration for publication elsewhere, either in whole or in part.
Finally, I hereby declare that I am aware that all the contents of the journal, except where otherwise noted, are licensed under a Creative Commons License (CC BY-NC 4.0), meaning that materials may be copied/reproduced, distributed, transmitted, and adapted for noncommercial purposes only, provided the original work is properly cited.
Name: _________________________________ Date: ____________
Revista Brasileira de Psiquiatria uses ScholarOne Manuscripts (http://mc.manuscriptcentral.com/rbp). Registration (login and password) is required on first access, prior to submission. For system support, please e-mail us at email@example.com.
[Home] [About this journal] [Editorial board] [Subscription]
All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License
Associação Brasileira de Psiquiatria
Rua Pedro de Toledo, 967 casa 1
04039-032 São Paulo SP Brasil
Tel.: +55 11 5081-6799
Fax: +55 11 5579-6210